← Leaderboards
Michael A Sandberg
Harvard University (Medical School)
$1,820,538
Attributed
$1,820,538
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $511.7K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,820,538 · 5
By mechanism
R03$886,476 · 2
R01$511,723 · 2
R21$422,339 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Tiansen Li$4,588,714
Others in their field
Top investigators on “Questionnaires”
- Jeffrey P Krischer · University Of South Florida$165,625,522
- David R. Weir · University Of Michigan At Ann Arbor$134,472,975
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Mine Cicek · Mayo Clinic Rochester$80,157,953
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$72,630,404
- Joseph B. Margolick · Johns Hopkins University$72,206,344
Research focus
QuestionnairesBaseInheritedVision DisordersScotomaVision AidRetinaOphthalmoscopyAssistive Device /TechnologyRehabilitationRetinitis PigmentosaBehavioral /Social Science Research TagStrokeTight JunctionsHuman SubjectGlaucomaComputer Program /SoftwareLongitudinal Human StudyPatient Oriented ResearchPerimetryRetina DegenerationReadingRetinal DegenerationVision Tests
Grant awards (10)
Modifiable Risk Factors for CME in Retinitis Pigmentosa$194,046
R21 · FY2010 · EY · contact PI
Modifiable Risk Factors for CME in Retinitis Pigmentosa$228,293
R21 · FY2009 · EY · contact PI
Models of Photoreceptor Disease$332,112
R01 · FY2008 · EY · contact PI
Therapies for Photoreceptor Degeneration$179,611
R01 · FY2008 · EY · contact PI
Melanopsin-based form vision in photoreceptor disease$164,590
R03 · FY2007 · EY · contact PI
Melanopsin-based form vision in photoreceptor disease$165,517
R03 · FY2006 · EY · contact PI
Melanopsin-based form vision in photoreceptor disease$169,500
R03 · FY2005 · EY
Reading Enhancement for Patients with Visual Field Loss$129,000
R03 · FY2004 · EY
Reading Enhancement for Patients with Visual Field Loss$129,000
R03 · FY2003 · EY
Reading Enhancement for Patients with Visual Field Loss$128,869
R03 · FY2001 · EY